Kenneth Offit

44.3k total citations · 1 hit paper
311 papers, 16.6k citations indexed

About

Kenneth Offit is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Kenneth Offit has authored 311 papers receiving a total of 16.6k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Genetics, 121 papers in Pathology and Forensic Medicine and 92 papers in Molecular Biology. Recurrent topics in Kenneth Offit's work include BRCA gene mutations in cancer (141 papers), Genetic factors in colorectal cancer (75 papers) and Cancer Genomics and Diagnostics (71 papers). Kenneth Offit is often cited by papers focused on BRCA gene mutations in cancer (141 papers), Genetic factors in colorectal cancer (75 papers) and Cancer Genomics and Diagnostics (71 papers). Kenneth Offit collaborates with scholars based in United States, Canada and United Kingdom. Kenneth Offit's co-authors include Mark E. Robson, Judy E. Garber, RS Chaganti, Larry Norton, Jaya M. Satagopan, Riccardo Dalla‐Favera, Jeff Boyd, Nathan A. Ellis, Noah D. Kauff and Khédoudja Nafa and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Kenneth Offit

296 papers receiving 16.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2Mutation

2002 891 citations Noah D. Kauff, Mark E. Robson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kenneth Offit	8.3k	5.8k	5.2k	4.9k	4.1k	311	16.6k
Mark E. Robson	9.1k 1.1×	3.2k 0.5×	8.0k 1.5×	5.9k 1.2×	6.0k 1.5×	412	19.5k
Peter Devilee	6.5k 0.8×	3.6k 0.6×	5.2k 1.0×	8.1k 1.7×	6.6k 1.6×	220	18.6k
Susan M. Domchek	8.8k 1.1×	2.5k 0.4×	10.2k 2.0×	6.0k 1.2×	4.9k 1.2×	334	19.7k
Yuri E. Nikiforov	6.0k 0.7×	3.5k 0.6×	6.9k 1.3×	7.3k 1.5×	2.8k 0.7×	250	32.8k
Sean V. Tavtigian	5.9k 0.7×	2.6k 0.4×	4.5k 0.9×	9.6k 2.0×	3.6k 0.9×	130	15.3k
Marina N. Nikiforova	3.6k 0.4×	3.0k 0.5×	5.6k 1.1×	5.4k 1.1×	3.8k 0.9×	209	18.8k
Karen H. Lu	3.9k 0.5×	4.2k 0.7×	6.8k 1.3×	7.4k 1.5×	4.8k 1.2×	427	21.6k
Margaret A. Tucker	3.4k 0.4×	1.9k 0.3×	7.3k 1.4×	4.7k 1.0×	2.9k 0.7×	230	16.0k
Rosalind A. Eeles	7.0k 0.8×	2.4k 0.4×	5.7k 1.1×	5.8k 1.2×	3.9k 0.9×	361	17.7k
Nadine Tung	5.9k 0.7×	1.6k 0.3×	5.7k 1.1×	3.9k 0.8×	3.8k 0.9×	190	11.3k

Countries citing papers authored by Kenneth Offit

Since Specialization

Citations

This map shows the geographic impact of Kenneth Offit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Offit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Offit more than expected).

Fields of papers citing papers by Kenneth Offit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Offit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Offit. The network helps show where Kenneth Offit may publish in the future.

Co-authorship network of co-authors of Kenneth Offit

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Offit. A scholar is included among the top collaborators of Kenneth Offit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Offit. Kenneth Offit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stopsack, Konrad H., Joseph Vijai, Jacob E. Berchuck, et al.. (2024). Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer. Clinical Cancer Research. 31(1). 122–129. 5 indexed citations

Mandelker, Diana, Antonio Marra, Nikita Mehta, et al.. (2023). Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations. npj Precision Oncology. 7(1). 34 indexed citations

Liu, Ying L., Karen A. Cadoo, Anna Maio, et al.. (2022). Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome. Genetics in Medicine. 24(6). 1187–1195. 10 indexed citations

Lu, Yujia, Yu Zhao, Jenny Chang‐Claude, et al.. (2022). Genetic Predictors for Fecal Propionate and Butyrate-Producing Microbiome Pathway Are Not Associated with Colorectal Cancer Risk: A Mendelian Randomization Analysis. Cancer Epidemiology Biomarkers & Prevention. 32(2). 281–286. 3 indexed citations

Song, Xiaoyu, Meng Ru, Zoe Steinsnyder, et al.. (2022). SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death. Cancer Epidemiology Biomarkers & Prevention. 31(7). 1466–1472. 3 indexed citations

Saldia, Amethyst, Sara H. Olson, Xiaolin Liang, et al.. (2019). Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. Cancer Prevention Research. 12(9). 599–608. 5 indexed citations

Ravichandran, Vignesh, Yelena Kemel, Michael F. Walsh, et al.. (2019). Toward automation of germline variant curation in clinical cancer genetics. Genetics in Medicine. 21(9). 2116–2125. 21 indexed citations

Artomov, Mykyta, Joseph Vijai, Grace Tiao, et al.. (2019). Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes. European Journal of Human Genetics. 27(5). 824–828. 4 indexed citations

Lencz, Todd, Jin Yu, Cameron D. Palmer, et al.. (2018). High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Human Genetics. 137(4). 343–355. 15 indexed citations

10.

Milko, Laura V., Birgit Funke, Ray E. Hershberger, et al.. (2018). Development of Clinical Domain Working Groups for the Clinical Genome Resource (ClinGen): lessons learned and plans for the future. Genetics in Medicine. 21(4). 987–993. 13 indexed citations

11.

Goddard, Katrina A.B., Evelyn P Whitlock, Jonathan S. Berg, et al.. (2013). Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genetics in Medicine. 15(9). 721–728. 31 indexed citations

12.

Comen, Elizabeth, et al.. (2011). Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women. Breast Cancer Research and Treatment. 129(1). 185–190. 75 indexed citations

13.

Klein, Robert J., Christer Halldén, Angel M. Cronin, et al.. (2010). Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer. Cancer Prevention Research. 3(5). 611–619. 45 indexed citations

14.

Kirchhoff, Tomas, Zhang-qun Chen, Bert Gold, et al.. (2009). The 6q22.33 Locus and Breast Cancer Susceptibility. Cancer Epidemiology Biomarkers & Prevention. 18(9). 2468–2475. 15 indexed citations

15.

Bacolod, Manny D., Shuang Wang, Richard Shattock, et al.. (2008). The Signatures of Autozygosity among Patients with Colorectal Cancer. Cancer Research. 68(8). 2610–2621. 40 indexed citations

16.

Kauff, Noah D., Susan M. Domchek, Tara M. Friebel, et al.. (2008). Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study. Journal of Clinical Oncology. 26(8). 1331–1337. 381 indexed citations

17.

Mitra, Nandita, Alex Smith, Shaokun Chuai, et al.. (2004). Localization of Cancer Susceptibility Genes by Genome-wide Single-Nucleotide Polymorphism Linkage-Disequilibrium Mapping. Cancer Research. 64(21). 8116–8125. 11 indexed citations

18.

Kauff, Noah D., Lauren Scheuer, Mark E. Robson, et al.. (2001). Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations. Genetics in Medicine. 3(6). 422–425. 16 indexed citations

19.

Straus, David J., George Y. Wong, John Liu, et al.. (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. The American Journal of Medicine. 90(3). 328–337. 41 indexed citations

20.

Offit, Kenneth, et al.. (1990). Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.. PubMed. 4(9). 625–30. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact